nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—HTR2C—type 2 diabetes mellitus	0.12	0.372	CbGaD
Fluoxetine—CYP1A2—type 2 diabetes mellitus	0.0903	0.281	CbGaD
Fluoxetine—CYP3A4—type 2 diabetes mellitus	0.0598	0.186	CbGaD
Fluoxetine—ALB—type 2 diabetes mellitus	0.0521	0.162	CbGaD
Fluoxetine—ORM1—Nateglinide—type 2 diabetes mellitus	0.0269	0.0602	CbGbCtD
Fluoxetine—ALB—Gliclazide—type 2 diabetes mellitus	0.0176	0.0393	CbGbCtD
Fluoxetine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0169	0.0377	CbGbCtD
Fluoxetine—ALB—Repaglinide—type 2 diabetes mellitus	0.0165	0.0369	CbGbCtD
Fluoxetine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0152	0.034	CbGbCtD
Fluoxetine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0138	0.0308	CbGbCtD
Fluoxetine—ALB—Valsartan—type 2 diabetes mellitus	0.0122	0.0272	CbGbCtD
Fluoxetine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0121	0.0271	CbGbCtD
Fluoxetine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0114	0.0255	CbGbCtD
Fluoxetine—ALB—Nateglinide—type 2 diabetes mellitus	0.0113	0.0253	CbGbCtD
Fluoxetine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0111	0.0249	CbGbCtD
Fluoxetine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0108	0.0242	CbGbCtD
Fluoxetine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0102	0.0228	CbGbCtD
Fluoxetine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00968	0.0217	CbGbCtD
Fluoxetine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00968	0.0217	CbGbCtD
Fluoxetine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00946	0.0212	CbGbCtD
Fluoxetine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00909	0.0204	CbGbCtD
Fluoxetine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00893	0.02	CbGbCtD
Fluoxetine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00863	0.0193	CbGbCtD
Fluoxetine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00824	0.0184	CbGbCtD
Fluoxetine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00805	0.018	CbGbCtD
Fluoxetine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00805	0.018	CbGbCtD
Fluoxetine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00781	0.0175	CbGbCtD
Fluoxetine—ALB—Glyburide—type 2 diabetes mellitus	0.00764	0.0171	CbGbCtD
Fluoxetine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00743	0.0166	CbGbCtD
Fluoxetine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00736	0.0165	CbGbCtD
Fluoxetine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00726	0.0162	CbGbCtD
Fluoxetine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00717	0.0161	CbGbCtD
Fluoxetine—ALB—Losartan—type 2 diabetes mellitus	0.00699	0.0156	CbGbCtD
Fluoxetine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00679	0.0152	CbGbCtD
Fluoxetine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00656	0.0147	CbGbCtD
Fluoxetine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00649	0.0145	CbGbCtD
Fluoxetine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00647	0.0145	CbGbCtD
Fluoxetine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00614	0.0137	CbGbCtD
Fluoxetine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0061	0.0136	CbGbCtD
Fluoxetine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00592	0.0132	CbGbCtD
Fluoxetine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00585	0.0131	CbGbCtD
Fluoxetine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00562	0.0126	CbGbCtD
Fluoxetine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00558	0.0125	CbGbCtD
Fluoxetine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00537	0.012	CbGbCtD
Fluoxetine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00535	0.012	CbGbCtD
Fluoxetine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00517	0.0116	CbGbCtD
Fluoxetine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00496	0.0111	CbGbCtD
Fluoxetine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00468	0.0105	CbGbCtD
Fluoxetine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00453	0.0101	CbGbCtD
Fluoxetine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00418	0.00936	CbGbCtD
Fluoxetine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00412	0.00922	CbGbCtD
Fluoxetine—ABCB1—Glyburide—type 2 diabetes mellitus	0.004	0.00895	CbGbCtD
Fluoxetine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00377	0.00843	CbGbCtD
Fluoxetine—ABCB1—Losartan—type 2 diabetes mellitus	0.00366	0.00818	CbGbCtD
Fluoxetine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00355	0.00794	CbGbCtD
Fluoxetine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0034	0.00761	CbGbCtD
Fluoxetine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0034	0.00761	CbGbCtD
Fluoxetine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00322	0.00719	CbGbCtD
Fluoxetine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0024	0.00536	CbGbCtD
Fluoxetine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00232	0.114	CbGeAlD
Fluoxetine—HTR2A—arteriole—type 2 diabetes mellitus	0.00219	0.108	CbGeAlD
Fluoxetine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00219	0.0049	CbGbCtD
Fluoxetine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00156	0.0768	CbGeAlD
Fluoxetine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0014	0.0687	CbGeAlD
Fluoxetine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000939	0.0462	CbGeAlD
Fluoxetine—SLC6A2—nerve—type 2 diabetes mellitus	0.000879	0.0432	CbGeAlD
Fluoxetine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000868	0.0427	CbGeAlD
Fluoxetine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000677	0.0333	CbGeAlD
Fluoxetine—HTR2A—artery—type 2 diabetes mellitus	0.000532	0.0262	CbGeAlD
Fluoxetine—HTR2A—nerve—type 2 diabetes mellitus	0.000528	0.026	CbGeAlD
Fluoxetine—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.00048	0.0236	CbGeAlD
Fluoxetine—HTR2A—endothelium—type 2 diabetes mellitus	0.00045	0.0221	CbGeAlD
Fluoxetine—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000387	0.019	CbGeAlD
Fluoxetine—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000337	0.0166	CbGeAlD
Fluoxetine—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000331	0.0163	CbGeAlD
Fluoxetine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000316	0.0155	CbGeAlD
Fluoxetine—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000306	0.0151	CbGeAlD
Fluoxetine—Duloxetine—HTR2C—type 2 diabetes mellitus	0.000295	0.215	CrCbGaD
Fluoxetine—Cinacalcet—CYP1A2—type 2 diabetes mellitus	0.000284	0.207	CrCbGaD
Fluoxetine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000254	0.0125	CbGeAlD
Fluoxetine—ORM1—liver—type 2 diabetes mellitus	0.000254	0.0125	CbGeAlD
Fluoxetine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000253	0.0124	CbGeAlD
Fluoxetine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000227	0.0112	CbGeAlD
Fluoxetine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000225	0.011	CbGeAlD
Fluoxetine—CYP3A5—kidney—type 2 diabetes mellitus	0.000223	0.011	CbGeAlD
Fluoxetine—Duloxetine—CYP1A2—type 2 diabetes mellitus	0.000223	0.162	CrCbGaD
Fluoxetine—ALB—liver—type 2 diabetes mellitus	0.000222	0.0109	CbGeAlD
Fluoxetine—CYP2B6—kidney—type 2 diabetes mellitus	0.000222	0.0109	CbGeAlD
Fluoxetine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000222	0.0109	CbGeAlD
Fluoxetine—HTR2A—retina—type 2 diabetes mellitus	0.000219	0.0108	CbGeAlD
Fluoxetine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000217	0.0107	CbGeAlD
Fluoxetine—SIGMAR1—liver—type 2 diabetes mellitus	0.000215	0.0106	CbGeAlD
Fluoxetine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000201	0.0099	CbGeAlD
Fluoxetine—Cinacalcet—CYP3A4—type 2 diabetes mellitus	0.000188	0.137	CrCbGaD
Fluoxetine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000185	0.0091	CbGeAlD
Fluoxetine—HTR2A—kidney—type 2 diabetes mellitus	0.000181	0.0089	CbGeAlD
Fluoxetine—CYP2C19—liver—type 2 diabetes mellitus	0.000179	0.00881	CbGeAlD
Fluoxetine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000168	0.00825	CbGeAlD
Fluoxetine—CYP3A4—kidney—type 2 diabetes mellitus	0.000168	0.00824	CbGeAlD
Fluoxetine—CYP2D6—kidney—type 2 diabetes mellitus	0.000165	0.00811	CbGeAlD
Fluoxetine—Atomoxetine—HTR2C—type 2 diabetes mellitus	0.000154	0.112	CrCbGaD
Fluoxetine—CYP1A2—liver—type 2 diabetes mellitus	0.000146	0.0072	CbGeAlD
Fluoxetine—ABCB1—retina—type 2 diabetes mellitus	0.000143	0.00705	CbGeAlD
Fluoxetine—CYP3A5—liver—type 2 diabetes mellitus	0.000141	0.00694	CbGeAlD
Fluoxetine—CYP2B6—liver—type 2 diabetes mellitus	0.00014	0.0069	CbGeAlD
Fluoxetine—CYP2C9—liver—type 2 diabetes mellitus	0.000139	0.00683	CbGeAlD
Fluoxetine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000135	0.00664	CbGeAlD
Fluoxetine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000121	0.00596	CbGeAlD
Fluoxetine—ABCB1—kidney—type 2 diabetes mellitus	0.000119	0.00584	CbGeAlD
Fluoxetine—ABCB1—pancreas—type 2 diabetes mellitus	0.000118	0.0058	CbGeAlD
Fluoxetine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000116	0.00568	CbGeAlD
Fluoxetine—HTR2A—liver—type 2 diabetes mellitus	0.000114	0.00563	CbGeAlD
Fluoxetine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000107	0.00526	CbGeAlD
Fluoxetine—CYP3A4—liver—type 2 diabetes mellitus	0.000106	0.00521	CbGeAlD
Fluoxetine—CYP2D6—liver—type 2 diabetes mellitus	0.000104	0.00513	CbGeAlD
Fluoxetine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	9.36e-05	0.0681	CrCbGaD
Fluoxetine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	7.72e-05	0.0562	CrCbGaD
Fluoxetine—ABCB1—liver—type 2 diabetes mellitus	7.5e-05	0.00369	CbGeAlD
Fluoxetine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	5.9e-05	0.0429	CrCbGaD
Fluoxetine—Arthralgia—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000263	CcSEcCtD
Fluoxetine—Chest pain—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000263	CcSEcCtD
Fluoxetine—Myalgia—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000263	CcSEcCtD
Fluoxetine—Shock—Metformin—type 2 diabetes mellitus	3.93e-05	0.000262	CcSEcCtD
Fluoxetine—Insomnia—Orlistat—type 2 diabetes mellitus	3.92e-05	0.000262	CcSEcCtD
Fluoxetine—Malaise—Losartan—type 2 diabetes mellitus	3.92e-05	0.000262	CcSEcCtD
Fluoxetine—Anxiety—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000262	CcSEcCtD
Fluoxetine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	3.92e-05	0.000262	CcSEcCtD
Fluoxetine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.91e-05	0.000261	CcSEcCtD
Fluoxetine—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.91e-05	0.000261	CcSEcCtD
Fluoxetine—Vertigo—Losartan—type 2 diabetes mellitus	3.91e-05	0.000261	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000261	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.9e-05	0.000261	CcSEcCtD
Fluoxetine—Somnolence—Valsartan—type 2 diabetes mellitus	3.9e-05	0.00026	CcSEcCtD
Fluoxetine—Syncope—Losartan—type 2 diabetes mellitus	3.9e-05	0.00026	CcSEcCtD
Fluoxetine—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.89e-05	0.00026	CcSEcCtD
Fluoxetine—Leukopenia—Losartan—type 2 diabetes mellitus	3.89e-05	0.00026	CcSEcCtD
Fluoxetine—Discomfort—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000259	CcSEcCtD
Fluoxetine—Skin disorder—Metformin—type 2 diabetes mellitus	3.88e-05	0.000259	CcSEcCtD
Fluoxetine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.86e-05	0.000258	CcSEcCtD
Fluoxetine—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.86e-05	0.000258	CcSEcCtD
Fluoxetine—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.85e-05	0.000257	CcSEcCtD
Fluoxetine—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000257	CcSEcCtD
Fluoxetine—Palpitations—Losartan—type 2 diabetes mellitus	3.84e-05	0.000257	CcSEcCtD
Fluoxetine—Nausea—Glimepiride—type 2 diabetes mellitus	3.83e-05	0.000256	CcSEcCtD
Fluoxetine—Arrhythmia—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000255	CcSEcCtD
Fluoxetine—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.82e-05	0.000255	CcSEcCtD
Fluoxetine—Nausea—Sitagliptin—type 2 diabetes mellitus	3.82e-05	0.000255	CcSEcCtD
Fluoxetine—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000255	CcSEcCtD
Fluoxetine—Asthenia—Glyburide—type 2 diabetes mellitus	3.82e-05	0.000255	CcSEcCtD
Fluoxetine—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.81e-05	0.000255	CcSEcCtD
Fluoxetine—Anorexia—Metformin—type 2 diabetes mellitus	3.81e-05	0.000254	CcSEcCtD
Fluoxetine—Cough—Losartan—type 2 diabetes mellitus	3.79e-05	0.000253	CcSEcCtD
Fluoxetine—Urticaria—Gliclazide—type 2 diabetes mellitus	3.79e-05	0.000253	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.79e-05	0.000253	CcSEcCtD
Fluoxetine—Alopecia—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000253	CcSEcCtD
Fluoxetine—Fatigue—Valsartan—type 2 diabetes mellitus	3.78e-05	0.000253	CcSEcCtD
Fluoxetine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.77e-05	0.000252	CcSEcCtD
Fluoxetine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.77e-05	0.000252	CcSEcCtD
Fluoxetine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.77e-05	0.000252	CcSEcCtD
Fluoxetine—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.77e-05	0.000252	CcSEcCtD
Fluoxetine—Pruritus—Glyburide—type 2 diabetes mellitus	3.76e-05	0.000251	CcSEcCtD
Fluoxetine—Mental disorder—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000251	CcSEcCtD
Fluoxetine—Constipation—Valsartan—type 2 diabetes mellitus	3.75e-05	0.000251	CcSEcCtD
Fluoxetine—Infection—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.00025	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.74e-05	0.00025	CcSEcCtD
Fluoxetine—Fatigue—Orlistat—type 2 diabetes mellitus	3.74e-05	0.00025	CcSEcCtD
Fluoxetine—Hypotension—Metformin—type 2 diabetes mellitus	3.73e-05	0.000249	CcSEcCtD
Fluoxetine—Malnutrition—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000249	CcSEcCtD
Fluoxetine—Shock—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000248	CcSEcCtD
Fluoxetine—Pain—Orlistat—type 2 diabetes mellitus	3.71e-05	0.000248	CcSEcCtD
Fluoxetine—Arthralgia—Losartan—type 2 diabetes mellitus	3.7e-05	0.000247	CcSEcCtD
Fluoxetine—Chest pain—Losartan—type 2 diabetes mellitus	3.7e-05	0.000247	CcSEcCtD
Fluoxetine—Myalgia—Losartan—type 2 diabetes mellitus	3.7e-05	0.000247	CcSEcCtD
Fluoxetine—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.7e-05	0.000247	CcSEcCtD
Fluoxetine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.69e-05	0.000247	CcSEcCtD
Fluoxetine—Anxiety—Losartan—type 2 diabetes mellitus	3.69e-05	0.000246	CcSEcCtD
Fluoxetine—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000246	CcSEcCtD
Fluoxetine—Rash—Bromocriptine—type 2 diabetes mellitus	3.67e-05	0.000245	CcSEcCtD
Fluoxetine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.66e-05	0.000245	CcSEcCtD
Fluoxetine—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.66e-05	0.000245	CcSEcCtD
Fluoxetine—Tension—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000244	CcSEcCtD
Fluoxetine—Discomfort—Losartan—type 2 diabetes mellitus	3.66e-05	0.000244	CcSEcCtD
Fluoxetine—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000244	CcSEcCtD
Fluoxetine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000243	CcSEcCtD
Fluoxetine—Headache—Bromocriptine—type 2 diabetes mellitus	3.64e-05	0.000243	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.64e-05	0.000243	CcSEcCtD
Fluoxetine—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.64e-05	0.000243	CcSEcCtD
Fluoxetine—Nervousness—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000242	CcSEcCtD
Fluoxetine—Dry mouth—Losartan—type 2 diabetes mellitus	3.62e-05	0.000242	CcSEcCtD
Fluoxetine—Anorexia—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.00024	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.59e-05	0.00024	CcSEcCtD
Fluoxetine—Paraesthesia—Metformin—type 2 diabetes mellitus	3.59e-05	0.00024	CcSEcCtD
Fluoxetine—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000239	CcSEcCtD
Fluoxetine—Confusional state—Losartan—type 2 diabetes mellitus	3.58e-05	0.000239	CcSEcCtD
Fluoxetine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000239	CcSEcCtD
Fluoxetine—Dyspnoea—Metformin—type 2 diabetes mellitus	3.56e-05	0.000238	CcSEcCtD
Fluoxetine—Somnolence—Metformin—type 2 diabetes mellitus	3.55e-05	0.000237	CcSEcCtD
Fluoxetine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.55e-05	0.000237	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.54e-05	0.000237	CcSEcCtD
Fluoxetine—Infection—Losartan—type 2 diabetes mellitus	3.52e-05	0.000235	CcSEcCtD
Fluoxetine—Hypotension—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000235	CcSEcCtD
Fluoxetine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.52e-05	0.000235	CcSEcCtD
Fluoxetine—Dyspepsia—Metformin—type 2 diabetes mellitus	3.52e-05	0.000235	CcSEcCtD
Fluoxetine—Tremor—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000233	CcSEcCtD
Fluoxetine—Shock—Losartan—type 2 diabetes mellitus	3.49e-05	0.000233	CcSEcCtD
Fluoxetine—Urticaria—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000233	CcSEcCtD
Fluoxetine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.47e-05	0.000232	CcSEcCtD
Fluoxetine—Decreased appetite—Metformin—type 2 diabetes mellitus	3.47e-05	0.000232	CcSEcCtD
Fluoxetine—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.47e-05	0.000232	CcSEcCtD
Fluoxetine—Tachycardia—Losartan—type 2 diabetes mellitus	3.46e-05	0.000231	CcSEcCtD
Fluoxetine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000231	CcSEcCtD
Fluoxetine—Nausea—Bromocriptine—type 2 diabetes mellitus	3.46e-05	0.000231	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.45e-05	0.00023	CcSEcCtD
Fluoxetine—Fatigue—Metformin—type 2 diabetes mellitus	3.44e-05	0.00023	CcSEcCtD
Fluoxetine—Urticaria—Orlistat—type 2 diabetes mellitus	3.44e-05	0.00023	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000229	CcSEcCtD
Fluoxetine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.43e-05	0.000229	CcSEcCtD
Fluoxetine—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000229	CcSEcCtD
Fluoxetine—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000229	CcSEcCtD
Fluoxetine—Asthenia—Gliclazide—type 2 diabetes mellitus	3.43e-05	0.000229	CcSEcCtD
Fluoxetine—Agitation—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000229	CcSEcCtD
Fluoxetine—Constipation—Metformin—type 2 diabetes mellitus	3.42e-05	0.000228	CcSEcCtD
Fluoxetine—Angioedema—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000227	CcSEcCtD
Fluoxetine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000226	CcSEcCtD
Fluoxetine—Anorexia—Losartan—type 2 diabetes mellitus	3.38e-05	0.000226	CcSEcCtD
Fluoxetine—Vomiting—Glyburide—type 2 diabetes mellitus	3.38e-05	0.000226	CcSEcCtD
Fluoxetine—Pruritus—Gliclazide—type 2 diabetes mellitus	3.38e-05	0.000226	CcSEcCtD
Fluoxetine—Malaise—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000224	CcSEcCtD
Fluoxetine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.36e-05	0.000224	CcSEcCtD
Fluoxetine—Rash—Glyburide—type 2 diabetes mellitus	3.35e-05	0.000224	CcSEcCtD
Fluoxetine—Somnolence—Irbesartan—type 2 diabetes mellitus	3.35e-05	0.000224	CcSEcCtD
Fluoxetine—Dermatitis—Glyburide—type 2 diabetes mellitus	3.35e-05	0.000224	CcSEcCtD
Fluoxetine—Vertigo—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000224	CcSEcCtD
Fluoxetine—Syncope—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000223	CcSEcCtD
Fluoxetine—Leukopenia—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000223	CcSEcCtD
Fluoxetine—Headache—Glyburide—type 2 diabetes mellitus	3.33e-05	0.000222	CcSEcCtD
Fluoxetine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000222	CcSEcCtD
Fluoxetine—Hypotension—Losartan—type 2 diabetes mellitus	3.32e-05	0.000221	CcSEcCtD
Fluoxetine—Palpitations—Ramipril—type 2 diabetes mellitus	3.29e-05	0.00022	CcSEcCtD
Fluoxetine—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.29e-05	0.00022	CcSEcCtD
Fluoxetine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000219	CcSEcCtD
Fluoxetine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000219	CcSEcCtD
Fluoxetine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.27e-05	0.000218	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.27e-05	0.000218	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000217	CcSEcCtD
Fluoxetine—Cough—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000217	CcSEcCtD
Fluoxetine—Fatigue—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000217	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.23e-05	0.000216	CcSEcCtD
Fluoxetine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.23e-05	0.000216	CcSEcCtD
Fluoxetine—Convulsion—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000216	CcSEcCtD
Fluoxetine—Pain—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000215	CcSEcCtD
Fluoxetine—Constipation—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000215	CcSEcCtD
Fluoxetine—Insomnia—Losartan—type 2 diabetes mellitus	3.21e-05	0.000214	CcSEcCtD
Fluoxetine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.19e-05	0.000213	CcSEcCtD
Fluoxetine—Paraesthesia—Losartan—type 2 diabetes mellitus	3.19e-05	0.000213	CcSEcCtD
Fluoxetine—Urticaria—Metformin—type 2 diabetes mellitus	3.17e-05	0.000212	CcSEcCtD
Fluoxetine—Myalgia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000212	CcSEcCtD
Fluoxetine—Chest pain—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000212	CcSEcCtD
Fluoxetine—Arthralgia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000212	CcSEcCtD
Fluoxetine—Dyspnoea—Losartan—type 2 diabetes mellitus	3.16e-05	0.000211	CcSEcCtD
Fluoxetine—Anxiety—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000211	CcSEcCtD
Fluoxetine—Nausea—Glyburide—type 2 diabetes mellitus	3.16e-05	0.000211	CcSEcCtD
Fluoxetine—Abdominal pain—Metformin—type 2 diabetes mellitus	3.16e-05	0.000211	CcSEcCtD
Fluoxetine—Dizziness—Gliclazide—type 2 diabetes mellitus	3.16e-05	0.000211	CcSEcCtD
Fluoxetine—Somnolence—Losartan—type 2 diabetes mellitus	3.15e-05	0.000211	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.15e-05	0.00021	CcSEcCtD
Fluoxetine—Asthenia—Valsartan—type 2 diabetes mellitus	3.15e-05	0.00021	CcSEcCtD
Fluoxetine—Discomfort—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000209	CcSEcCtD
Fluoxetine—Dyspepsia—Losartan—type 2 diabetes mellitus	3.12e-05	0.000209	CcSEcCtD
Fluoxetine—Asthenia—Orlistat—type 2 diabetes mellitus	3.11e-05	0.000208	CcSEcCtD
Fluoxetine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.000207	CcSEcCtD
Fluoxetine—Pruritus—Valsartan—type 2 diabetes mellitus	3.1e-05	0.000207	CcSEcCtD
Fluoxetine—Dry mouth—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000207	CcSEcCtD
Fluoxetine—Decreased appetite—Losartan—type 2 diabetes mellitus	3.08e-05	0.000206	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000206	CcSEcCtD
Fluoxetine—Confusional state—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000205	CcSEcCtD
Fluoxetine—Pruritus—Orlistat—type 2 diabetes mellitus	3.07e-05	0.000205	CcSEcCtD
Fluoxetine—Fatigue—Losartan—type 2 diabetes mellitus	3.06e-05	0.000204	CcSEcCtD
Fluoxetine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000203	CcSEcCtD
Fluoxetine—Vomiting—Gliclazide—type 2 diabetes mellitus	3.04e-05	0.000203	CcSEcCtD
Fluoxetine—Pain—Losartan—type 2 diabetes mellitus	3.03e-05	0.000203	CcSEcCtD
Fluoxetine—Constipation—Losartan—type 2 diabetes mellitus	3.03e-05	0.000203	CcSEcCtD
Fluoxetine—Rash—Gliclazide—type 2 diabetes mellitus	3.01e-05	0.000201	CcSEcCtD
Fluoxetine—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.01e-05	0.000201	CcSEcCtD
Fluoxetine—Diarrhoea—Valsartan—type 2 diabetes mellitus	3e-05	0.0002	CcSEcCtD
Fluoxetine—Urticaria—Irbesartan—type 2 diabetes mellitus	2.99e-05	0.0002	CcSEcCtD
Fluoxetine—Shock—Ramipril—type 2 diabetes mellitus	2.99e-05	0.0002	CcSEcCtD
Fluoxetine—Headache—Gliclazide—type 2 diabetes mellitus	2.99e-05	0.0002	CcSEcCtD
Fluoxetine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000199	CcSEcCtD
Fluoxetine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000199	CcSEcCtD
Fluoxetine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.98e-05	0.000199	CcSEcCtD
Fluoxetine—Tachycardia—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000198	CcSEcCtD
Fluoxetine—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.97e-05	0.000198	CcSEcCtD
Fluoxetine—Skin disorder—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000197	CcSEcCtD
Fluoxetine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000196	CcSEcCtD
Fluoxetine—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.92e-05	0.000195	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.9e-05	0.000194	CcSEcCtD
Fluoxetine—Dizziness—Valsartan—type 2 diabetes mellitus	2.9e-05	0.000194	CcSEcCtD
Fluoxetine—Anorexia—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000194	CcSEcCtD
Fluoxetine—Dizziness—Orlistat—type 2 diabetes mellitus	2.87e-05	0.000191	CcSEcCtD
Fluoxetine—Asthenia—Metformin—type 2 diabetes mellitus	2.87e-05	0.000191	CcSEcCtD
Fluoxetine—Hypotension—Ramipril—type 2 diabetes mellitus	2.84e-05	0.00019	CcSEcCtD
Fluoxetine—Nausea—Gliclazide—type 2 diabetes mellitus	2.84e-05	0.000189	CcSEcCtD
Fluoxetine—Pruritus—Metformin—type 2 diabetes mellitus	2.83e-05	0.000189	CcSEcCtD
Fluoxetine—Urticaria—Losartan—type 2 diabetes mellitus	2.82e-05	0.000188	CcSEcCtD
Fluoxetine—Body temperature increased—Losartan—type 2 diabetes mellitus	2.8e-05	0.000187	CcSEcCtD
Fluoxetine—Abdominal pain—Losartan—type 2 diabetes mellitus	2.8e-05	0.000187	CcSEcCtD
Fluoxetine—Vomiting—Valsartan—type 2 diabetes mellitus	2.79e-05	0.000186	CcSEcCtD
Fluoxetine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.78e-05	0.000185	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000185	CcSEcCtD
Fluoxetine—Rash—Valsartan—type 2 diabetes mellitus	2.77e-05	0.000185	CcSEcCtD
Fluoxetine—Dermatitis—Valsartan—type 2 diabetes mellitus	2.76e-05	0.000185	CcSEcCtD
Fluoxetine—Vomiting—Orlistat—type 2 diabetes mellitus	2.76e-05	0.000184	CcSEcCtD
Fluoxetine—Insomnia—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000184	CcSEcCtD
Fluoxetine—Headache—Valsartan—type 2 diabetes mellitus	2.75e-05	0.000184	CcSEcCtD
Fluoxetine—Diarrhoea—Metformin—type 2 diabetes mellitus	2.73e-05	0.000183	CcSEcCtD
Fluoxetine—Rash—Orlistat—type 2 diabetes mellitus	2.73e-05	0.000183	CcSEcCtD
Fluoxetine—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000182	CcSEcCtD
Fluoxetine—Dermatitis—Orlistat—type 2 diabetes mellitus	2.73e-05	0.000182	CcSEcCtD
Fluoxetine—Headache—Orlistat—type 2 diabetes mellitus	2.72e-05	0.000181	CcSEcCtD
Fluoxetine—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.71e-05	0.000181	CcSEcCtD
Fluoxetine—Asthenia—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000181	CcSEcCtD
Fluoxetine—Somnolence—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000181	CcSEcCtD
Fluoxetine—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000179	CcSEcCtD
Fluoxetine—Pruritus—Irbesartan—type 2 diabetes mellitus	2.67e-05	0.000178	CcSEcCtD
Fluoxetine—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000177	CcSEcCtD
Fluoxetine—Dizziness—Metformin—type 2 diabetes mellitus	2.64e-05	0.000176	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000175	CcSEcCtD
Fluoxetine—Fatigue—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000175	CcSEcCtD
Fluoxetine—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.61e-05	0.000175	CcSEcCtD
Fluoxetine—Nausea—Valsartan—type 2 diabetes mellitus	2.61e-05	0.000174	CcSEcCtD
Fluoxetine—Constipation—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000174	CcSEcCtD
Fluoxetine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.58e-05	0.000172	CcSEcCtD
Fluoxetine—Nausea—Orlistat—type 2 diabetes mellitus	2.57e-05	0.000172	CcSEcCtD
Fluoxetine—Asthenia—Losartan—type 2 diabetes mellitus	2.55e-05	0.00017	CcSEcCtD
Fluoxetine—Vomiting—Metformin—type 2 diabetes mellitus	2.54e-05	0.00017	CcSEcCtD
Fluoxetine—Rash—Metformin—type 2 diabetes mellitus	2.52e-05	0.000168	CcSEcCtD
Fluoxetine—Dermatitis—Metformin—type 2 diabetes mellitus	2.52e-05	0.000168	CcSEcCtD
Fluoxetine—Pruritus—Losartan—type 2 diabetes mellitus	2.51e-05	0.000168	CcSEcCtD
Fluoxetine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000167	CcSEcCtD
Fluoxetine—Headache—Metformin—type 2 diabetes mellitus	2.5e-05	0.000167	CcSEcCtD
Fluoxetine—Dizziness—Irbesartan—type 2 diabetes mellitus	2.49e-05	0.000166	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000166	CcSEcCtD
Fluoxetine—Diarrhoea—Losartan—type 2 diabetes mellitus	2.43e-05	0.000162	CcSEcCtD
Fluoxetine—Urticaria—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000161	CcSEcCtD
Fluoxetine—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000161	CcSEcCtD
Fluoxetine—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000161	CcSEcCtD
Fluoxetine—Vomiting—Irbesartan—type 2 diabetes mellitus	2.4e-05	0.00016	CcSEcCtD
Fluoxetine—Rash—Irbesartan—type 2 diabetes mellitus	2.38e-05	0.000159	CcSEcCtD
Fluoxetine—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.37e-05	0.000159	CcSEcCtD
Fluoxetine—Nausea—Metformin—type 2 diabetes mellitus	2.37e-05	0.000158	CcSEcCtD
Fluoxetine—Headache—Irbesartan—type 2 diabetes mellitus	2.36e-05	0.000158	CcSEcCtD
Fluoxetine—Dizziness—Losartan—type 2 diabetes mellitus	2.35e-05	0.000157	CcSEcCtD
Fluoxetine—Vomiting—Losartan—type 2 diabetes mellitus	2.26e-05	0.000151	CcSEcCtD
Fluoxetine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.24e-05	0.00015	CcSEcCtD
Fluoxetine—Nausea—Irbesartan—type 2 diabetes mellitus	2.24e-05	0.00015	CcSEcCtD
Fluoxetine—Rash—Losartan—type 2 diabetes mellitus	2.24e-05	0.000149	CcSEcCtD
Fluoxetine—Dermatitis—Losartan—type 2 diabetes mellitus	2.23e-05	0.000149	CcSEcCtD
Fluoxetine—Headache—Losartan—type 2 diabetes mellitus	2.22e-05	0.000148	CcSEcCtD
Fluoxetine—Asthenia—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000146	CcSEcCtD
Fluoxetine—Pruritus—Ramipril—type 2 diabetes mellitus	2.15e-05	0.000144	CcSEcCtD
Fluoxetine—Nausea—Losartan—type 2 diabetes mellitus	2.11e-05	0.000141	CcSEcCtD
Fluoxetine—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.08e-05	0.000139	CcSEcCtD
Fluoxetine—Dizziness—Ramipril—type 2 diabetes mellitus	2.01e-05	0.000134	CcSEcCtD
Fluoxetine—Vomiting—Ramipril—type 2 diabetes mellitus	1.93e-05	0.000129	CcSEcCtD
Fluoxetine—Rash—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000128	CcSEcCtD
Fluoxetine—Dermatitis—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000128	CcSEcCtD
Fluoxetine—Headache—Ramipril—type 2 diabetes mellitus	1.91e-05	0.000127	CcSEcCtD
Fluoxetine—Nausea—Ramipril—type 2 diabetes mellitus	1.81e-05	0.000121	CcSEcCtD
Fluoxetine—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	2.73e-06	4.55e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.73e-06	4.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.72e-06	4.54e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.72e-06	4.54e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.72e-06	4.54e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GPX1—type 2 diabetes mellitus	2.72e-06	4.54e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.71e-06	4.53e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.7e-06	4.51e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.69e-06	4.49e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.68e-06	4.48e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.68e-06	4.48e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.68e-06	4.48e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	2.67e-06	4.47e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.67e-06	4.46e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CD36—type 2 diabetes mellitus	2.65e-06	4.42e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.63e-06	4.4e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.63e-06	4.4e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.62e-06	4.37e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.62e-06	4.37e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2.61e-06	4.36e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.59e-06	4.33e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.59e-06	4.32e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.58e-06	4.32e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.58e-06	4.31e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.57e-06	4.3e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.56e-06	4.28e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.56e-06	4.27e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.55e-06	4.25e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.53e-06	4.22e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.53e-06	4.22e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.53e-06	4.22e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.53e-06	4.22e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.52e-06	4.22e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.51e-06	4.2e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.51e-06	4.2e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.51e-06	4.19e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.5e-06	4.18e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.5e-06	4.18e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.5e-06	4.18e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.49e-06	4.16e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.49e-06	4.15e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.48e-06	4.15e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.48e-06	4.15e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.48e-06	4.14e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.48e-06	4.14e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.46e-06	4.12e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.46e-06	4.12e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.46e-06	4.12e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPARA—type 2 diabetes mellitus	2.46e-06	4.11e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.46e-06	4.11e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.46e-06	4.1e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.45e-06	4.09e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.45e-06	4.09e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.44e-06	4.08e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.44e-06	4.07e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.42e-06	4.05e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.42e-06	4.04e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.41e-06	4.02e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.4e-06	4.02e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.39e-06	3.99e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.39e-06	3.99e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.38e-06	3.98e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.38e-06	3.98e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.38e-06	3.97e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.38e-06	3.97e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	3.96e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.36e-06	3.94e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.35e-06	3.92e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.35e-06	3.92e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.35e-06	3.92e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.34e-06	3.91e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.34e-06	3.91e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.33e-06	3.9e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.32e-06	3.88e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.32e-06	3.88e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.32e-06	3.87e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.32e-06	3.87e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.31e-06	3.85e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.3e-06	3.84e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.29e-06	3.82e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.28e-06	3.82e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.28e-06	3.81e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.25e-06	3.76e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.25e-06	3.76e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.25e-06	3.75e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.24e-06	3.75e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.24e-06	3.75e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.23e-06	3.73e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.23e-06	3.73e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.22e-06	3.72e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.21e-06	3.69e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.21e-06	3.69e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.21e-06	3.69e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.21e-06	3.69e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.21e-06	3.69e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.2e-06	3.67e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	3.65e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	3.63e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.17e-06	3.62e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.17e-06	3.62e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.16e-06	3.6e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.16e-06	3.6e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.15e-06	3.59e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.14e-06	3.57e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.14e-06	3.57e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.14e-06	3.57e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.14e-06	3.57e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.13e-06	3.56e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.13e-06	3.56e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.12e-06	3.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.1e-06	3.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-06	3.51e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.1e-06	3.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.1e-06	3.5e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.09e-06	3.49e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	3.47e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	3.47e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.07e-06	3.46e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.07e-06	3.46e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.05e-06	3.43e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.05e-06	3.43e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.05e-06	3.42e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.04e-06	3.41e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.04e-06	3.4e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.04e-06	3.4e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.03e-06	3.4e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.03e-06	3.39e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.03e-06	3.39e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.03e-06	3.39e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.02e-06	3.38e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.02e-06	3.38e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.01e-06	3.36e-05	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.01e-06	3.36e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2e-06	3.34e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2e-06	3.34e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—INS—type 2 diabetes mellitus	1.99e-06	3.33e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.99e-06	3.33e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.98e-06	3.32e-05	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.98e-06	3.31e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.98e-06	3.3e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.97e-06	3.29e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.95e-06	3.26e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.95e-06	3.25e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	3.23e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.93e-06	3.22e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.92e-06	3.2e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.92e-06	3.2e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.92e-06	3.2e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.92e-06	3.2e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.91e-06	3.19e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.91e-06	3.19e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.91e-06	3.18e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.9e-06	3.17e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	3.17e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.89e-06	3.16e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.88e-06	3.14e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.86e-06	3.11e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.86e-06	3.1e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.85e-06	3.09e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.83e-06	3.05e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.83e-06	3.05e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.82e-06	3.05e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.79e-06	2.99e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.78e-06	2.98e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.75e-06	2.93e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.75e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.75e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.75e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.74e-06	2.92e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.73e-06	2.9e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.73e-06	2.89e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.72e-06	2.87e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.72e-06	2.87e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.69e-06	2.82e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.68e-06	2.8e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.67e-06	2.78e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.66e-06	2.78e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.65e-06	2.76e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.65e-06	2.76e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	2.75e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.64e-06	2.75e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.64e-06	2.74e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.64e-06	2.74e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.63e-06	2.73e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.63e-06	2.73e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.63e-06	2.73e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.62e-06	2.71e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.62e-06	2.7e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.61e-06	2.7e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	2.68e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	2.67e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.58e-06	2.65e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.57e-06	2.63e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	2.62e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	2.62e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.55e-06	2.59e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	2.56e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	2.56e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.53e-06	2.56e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.52e-06	2.54e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	2.52e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.51e-06	2.52e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.5e-06	2.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	2.5e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.47e-06	2.46e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.47e-06	2.45e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.47e-06	2.45e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	2.41e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	2.41e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.44e-06	2.4e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.43e-06	2.39e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.43e-06	2.39e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.43e-06	2.39e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.42e-06	2.38e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.41e-06	2.36e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	2.34e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.39e-06	2.33e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.35e-06	2.26e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.35e-06	2.25e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.33e-06	2.22e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	2.21e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.32e-06	2.21e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	2.19e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.29e-06	2.15e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.28e-06	2.14e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.26e-06	2.11e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.26e-06	2.11e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.25e-06	2.08e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-06	2.04e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-06	2.04e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.17e-06	1.95e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	1.87e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.83e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.08e-06	1.8e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.8e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.7e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.87e-07	1.65e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	9.55e-07	1.6e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	9.44e-07	1.58e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	9.44e-07	1.58e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.36e-07	1.56e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	9.33e-07	1.56e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.63e-07	1.44e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	8.04e-07	1.34e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	7.22e-07	1.21e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	7.04e-07	1.18e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.64e-07	1.11e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.58e-07	1.1e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.62e-07	9.39e-06	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.34e-07	7.25e-06	CbGpPWpGaD
